Krystal Biotech Inc (KRYS) — Long-term Investment Intensity
Krystal Biotech Inc (KRYS) has a Long-term Investment Intensity of 13.9% as of March 2026. Long-term investments of $193.49 Million represent 13.9% of total assets of $1.40 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check KRYS total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Krystal Biotech Inc Long-term Investment Intensity (2019–2025)
This chart shows how Krystal Biotech Inc's Long-term Investment Intensity has evolved across 6 annual periods from 2019 to 2025. As of March 2026, the intensity stands at 13.9%, reflecting long-term investments of $193.49 Million against total assets of $1.40 Billion USD. Explore debt repayment capacity of Krystal Biotech Inc to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Krystal Biotech Inc (2019–2025)
The table below presents the year-by-year Long-term Investment Intensity for Krystal Biotech Inc from 2019 to 2025, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see market value of Krystal Biotech Inc.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 9.6% | $128.07 Million | $1.33 Billion | ▼ -4.8 pp |
| 2024 | 14.4% | $152.11 Million | $1.06 Billion | ▲ +6.8 pp |
| 2023 | 7.6% | $61.95 Million | $818.36 Million | ▲ +6.7 pp |
| 2022 | 0.8% | $4.62 Million | $558.45 Million | ▼ -9.5 pp |
| 2021 | 10.3% | $64.37 Million | $626.29 Million | ▲ +10.0 pp |
| 2019 | 0.2% | $497.00K | $209.02 Million | — |